Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib Maintenance in mCRC (Bohème)
NCT05412706Phase 2Withdrawn
- Sponsor
- IRCCS Ospedale Policlinico San Martino
- Start
- Sep 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of niraparib in metastatic colorectal cancer (mCRC), sponsored by IRCCS Ospedale Policlinico San Martino. Planned start Sep 2023; status: withdrawn.
02
Drugs
niraparib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05412706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05412706.